[Secondary carcinoma: a complication of cytostatic therapy?].
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000139:chemically induced / Q000188:drug therapy; D002273:Carcinogens; D002699:Chlorambucil / Q000009:adverse effects; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007938:Leukemia / Q000139:chemically induced / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D009369:Neoplasms / Q000139:chemically induced*; D009378:Neoplasms, Multiple Primary / Q000209:etiology; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010954:Plasmacytoma / Q000188:drug therapy; D011087:Polycythemia Vera / Q000188:drug therapy; D013995:Time
D000970:Antineoplastic Agents; D002273:Carcinogens; D002699:Chlorambucil
Zweitkarzinome: eine Komplikation der zytostatischen Therapie?